366
Views
3
CrossRef citations to date
0
Altmetric
Alzheimer's Disease and Caregiving

Quality indicators of psychotropic prescribing to people with dementia in aged psychiatry inpatient units

ORCID Icon, , , , , , , , , , & show all
Pages 1432-1437 | Received 25 Apr 2017, Accepted 03 Aug 2017, Published online: 28 Aug 2017

References

  • American Geriatrics Society. (2015). American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 63, 2227–2246.
  • Australian Commission on Safety and Quality in Healthcare. (2011). National safety and quality health service standards. Sydney: ACSQHC.
  • Australian Commission on Safety and Quality in Healthcare. (2014). National quality use of medicines: Indicators for australian hospitals. Sydney: ACSQHC.
  • Australian Commission on Safety and Quality in Healthcare. (2015). Australian atlas of healthcare variation. Sydney: ACSQHC.
  • Australian Government. (2010). National standards for mental health services. Canberra: Commonwealth of Australia.
  • Australian Pharmaceutical Advisory Council. (2005). Guiding principles to achieve continuity in medication management. Canberra: Commonwealth of Australia.
  • Brodaty, H., Draper, B.M., & Low, L.F. (2003). Behavioural and psychological symptoms of dementia: A seven-tiered model of service delivery. Medical Journal of Australia, 178, 231–234.
  • Gobert, M., & D'hoore, W. (2005). Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. International Journal of Geriatric Psychiatry, 20, 712–721.
  • Greve, M., & O'Connor, D. (2005). A survey of Australian and New Zealand old age psychiatrists’ preferred medications to treat behavioural and psychological symptoms of dementia. International Psychogeriatrics, 17, 195–205.
  • Haw, C., Stoffels, M., Purkayastha, D.D., & Sudad, S. (2015). Antipsychotics for behavioral and psychiatric symptoms of dementia: A reaudit of a specialist inpatient services. International Psychogeriatrics, 27, 171–172.
  • International Psychogeriatrics Association. (2015). The IPA complete guides to behavioral and psychological symptoms of dementia: module 6. Chicago, IL; IPA, pp. 1–35.
  • Looi, J. C. L., Byrne, G.J., Macfarlane, S., McKay, R., & O'Connor, D.W. (2014). Systematic approach to behavioural and psychological symptoms of dementia in residential aged care facilities. Australian and New Zealand Journal of Psychiatry, 48, 112–115.
  • Mann, E., Köpke, S., Haastert, B., Pitkäla, K., & Meyer, G. (2009). Psychotropic medication use among nursing home residents in Austria: A cross-national study. BMC Geriatrics, 9 doi: 10.1186/1471-2318-9-18 9
  • National Health and Medical Research Council. (2014). Ethical considerations in quality assurance and evaluation activities. Canberra: Australian Government.
  • Nijk, R.M., Zuidema, S.U., & Koopmans, R. T. C. M. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485–493.
  • Nirodi, P., & Mitchell, A.J. (2002). The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly. Aging and Mental Health, 6, 191–196.
  • O'Connor, D.W., Ames, D., Gardner, B., & King, M. (2009a). Psychosocial treatments of psychological symptoms in dementia: A systematic review of reports meeting quality standards. International Psychogeriatrics, 21, 241–251.
  • O'Connor, D.W., Ames, D., Gardner, B., & King, M. (2009b). Psychosocial treatments of behavior symptoms in dementia: A systematic review of reports meeting quality standards. International Psychogeriatrics, 21, 225–240.
  • O'Connor, D.W., Griffith, J., & McSweeney, K. (2010). Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia. International Psychogeriatrics, 22, 1149–1153.
  • Pan, Y.J., Wu, C.S., Gau, S. S. F., Chan, H.Y., & Banerjee, S. (2014). Antipsychotic discontinuation in patients with dementia: A systematic review and meta-analysis of published controlled studies. Dementia and Geriatric Cognitive Disorders, 37, 125–140.
  • Seitz, D.P., Gill, S.S., & Herrmann, N., Seitz, D. P., Gill, S. S., Herrmann, N., Brisbin, S., Rapoport, M. J., Rines, J., Wilson, K., Le Clair, K. & Conn, D. K. (2013). Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: A systematic review. International Psychogeriatrics, 25, 185–203.
  • Snowdon, J., Day, S., & Baker, W. (2006). Current use of psychotropic medication in nursing homes. International Psychogeriatrics, 18, 241–250.
  • Wennberg, J.E., & Thomson, P.Y. (2011). Time to tackle unwarranted variations in practice. BMJ, 342, d1513.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.